Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 3/2023

22-02-2023 | Acute Liver Failure | Case Report

A case of acute liver failure due to aggressive natural killer-cell leukemia with a rapid course

Authors: Ai Toyodome, Seiichi Mawatari, Ohki Taniyama, Sho Ijuin, Haruka Sakae, Kazuaki Tabu, Kohei Oda, Kotaro Kumagai, Takashi Tasaki, Akio Ido

Published in: Clinical Journal of Gastroenterology | Issue 3/2023

Login to get access

Abstract

An 87-year-old man consulted a former doctor with a complaint of black stool and was admitted to hospital because of anemia and multiple gastric ulcers. The laboratory findings showed that his hepatobiliary enzyme levels and inflammatory response were elevated. Computed tomography showed hepatosplenomegaly and enlarged intra-abdominal lymph nodes. Two days later, he was transferred to our hospital due to deterioration of his liver function. Since he had low level of consciousness and his ammonia level was high, we diagnosed him with acute liver failure (ALF) with hepatic coma, and started on-line hemodiafiltration. As the cause of ALF, we suspected hepatic involvement of a hematologic tumor because of high lactate dehydrogenase and soluble interleukin-2 receptor levels and large abnormal lymphocyte-like cells in the peripheral blood. Because of his poor general condition, bone marrow and other histological examinations were difficult, and he died on the third day of hospitalization. Pathological autopsy showed marked hepatosplenomegaly and the proliferation of large abnormal lymphocyte-like cells in the bone marrow, liver, spleen, and lymph nodes. Immunostaining revealed aggressive natural killer-cell leukemia (ANKL).
We herein report a rare case of the development of ALF with coma due to ANKL with a review of the relevant literature.
Literature
1.
go back to reference Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia. 2004;18:763–70.CrossRefPubMed Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia. 2004;18:763–70.CrossRefPubMed
2.
go back to reference Mochida S, Takikawa Y, Nakayama N, et al. Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res. 2011;41:805–12.CrossRefPubMed Mochida S, Takikawa Y, Nakayama N, et al. Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res. 2011;41:805–12.CrossRefPubMed
3.
go back to reference The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000;50:696–702. The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000;50:696–702.
4.
go back to reference Ishida F. Diagnosis and managements of aggressive NK cell leukemia. Hematology. 2020;80:433–8. Ishida F. Diagnosis and managements of aggressive NK cell leukemia. Hematology. 2020;80:433–8.
5.
go back to reference Ishida F, Ko YH, Kim WS, et al. Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation. Cancer Sci. 2012;103:1079–83.CrossRefPubMedPubMedCentral Ishida F, Ko YH, Kim WS, et al. Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation. Cancer Sci. 2012;103:1079–83.CrossRefPubMedPubMedCentral
6.
go back to reference Suzuki R. Aggressive NK-cell leukemia. Nippon Rinsho. 2016;74:217–22. Suzuki R. Aggressive NK-cell leukemia. Nippon Rinsho. 2016;74:217–22.
7.
go back to reference Fujimoto A. Allogeneic stem cell transplantation for aggressive NK cell leukemia. Jpn J Clin Hematol. 2021;62:360–8. Fujimoto A. Allogeneic stem cell transplantation for aggressive NK cell leukemia. Jpn J Clin Hematol. 2021;62:360–8.
8.
go back to reference Ko YH, Park S, Kim K, et al. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis? Acta Haematol. 2008;120:199–206.CrossRefPubMed Ko YH, Park S, Kim K, et al. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis? Acta Haematol. 2008;120:199–206.CrossRefPubMed
10.
go back to reference Bi XW, Wang H, Zhang WW, et al. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma. J Hematol Oncol. 2016;9:109.CrossRefPubMedPubMedCentral Bi XW, Wang H, Zhang WW, et al. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma. J Hematol Oncol. 2016;9:109.CrossRefPubMedPubMedCentral
11.
12.
go back to reference Gao LM, Liu WP, Yang QP, et al. Aggressive natural killer-cell leukemia with jaundice and spontaneous splenic rupture: a case report and review of the literature. Diagn Pathol. 2013;8:43.CrossRefPubMedPubMedCentral Gao LM, Liu WP, Yang QP, et al. Aggressive natural killer-cell leukemia with jaundice and spontaneous splenic rupture: a case report and review of the literature. Diagn Pathol. 2013;8:43.CrossRefPubMedPubMedCentral
13.
go back to reference Dellon ES, Morris SR, Tang W, et al. Acute liver failure due to natural killer-like T-cell leukemia/lymphoma: a case report and review of the literature. World J Gastroenterol. 2006;12:4089–92.CrossRefPubMedPubMedCentral Dellon ES, Morris SR, Tang W, et al. Acute liver failure due to natural killer-like T-cell leukemia/lymphoma: a case report and review of the literature. World J Gastroenterol. 2006;12:4089–92.CrossRefPubMedPubMedCentral
Metadata
Title
A case of acute liver failure due to aggressive natural killer-cell leukemia with a rapid course
Authors
Ai Toyodome
Seiichi Mawatari
Ohki Taniyama
Sho Ijuin
Haruka Sakae
Kazuaki Tabu
Kohei Oda
Kotaro Kumagai
Takashi Tasaki
Akio Ido
Publication date
22-02-2023
Publisher
Springer Nature Singapore
Published in
Clinical Journal of Gastroenterology / Issue 3/2023
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-023-01771-4

Other articles of this Issue 3/2023

Clinical Journal of Gastroenterology 3/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine